Stoke Therapeutics Inc (NASDAQ:STOK)
| 3.94 Delayed Data As of Dec 01 |  +0.16 / +4.22%Today’s Change | 3.35 Today|||52-Week Range 14.00 | -57.31% Year-to-Date |
Latest STOK News | Press Releases
No recent news for Stoke Therapeutics Inc.
Today’s Trading
| Previous close | 3.79 |
| Today’s open | 3.84 |
| Day’s range | 3.77 - 4.03 |
| Volume | 140,125 |
| Average volume (3 months) | 273,064 |
| Market cap | $176.4M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -11.25% |
| Earnings growth (this year) | +4.57% |
| Earnings growth (next 5 years) | -4.88% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 28.94 |
| Price/Book | 0.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HMTXFHemostemix Inc | -0.00 | -0.22% |
| KAKineta Inc | +0.23 | +6.08% |
| WVEWAVE Life Sciences L... | +0.20 | +3.77% |
| EDITEditas Medicine Inc | +0.24 | +2.28% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | March 6, 2024 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $12.4M |
| Annual profit (last year) | -$101.1M |
| Net profit margin | -814.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bedford, Massachusetts |
Forecasts
